Role of Foxo1 gene expression in mechanism of antihypertrophic action of metformin in cardiomyocytes
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 7
Abstract
Background. Diabetic cardiomyopathy is the leading cause of mortality in patients with type 2 diabetes mellitus. Hypertrophy of cardiomyocytes is one of the main pathomorphological signs of diabetic cardiomyopathy development. Metformin, the first-line drug for the treatment of type 2 diabetes mellitus, along with hypoglycaemic effects, exerts cardioprotective effects. However, the mechanism of metformin action in cardiomyocytes remains unclear. The purpose of the study was to investigate the role of Foxo1 gene expression in the mechanism of antihypertrophic action of metformin in cardiomyocytes. Materials and methods. H9C2 cells were transfected with siRNA Fохо1 and siRNA negative control. Cells were deprived in 0% medium for 24 hours, treated with metformin (5mM) 30 min before cell stress, then put into hypoxic chamber for 16 hours and reoxygenated for 4 hours. Cell area was quantified using ImageJ. Knockdown efficiency was confirmed by real time polymerase chain reaction. Results. At the normal functioning of Fохо1 gene, metformin has the expressed antihypertrophic action under hypoxia. However, blocking Fохо1 gene expression deprives preparation of this effect and causes the hypertrophy of Н9С2 cells in all conditions of the experiment. Conclusions. The strong hypertrophic response in the group of H9C2 cells transfected with siRNA Foxo1 cultured under hypoxia with metformin treatment may be a result of following mechanisms: a) metformin prevents hypertrophy through Foxo1 pathway, thus, Foxo1 silencing totally blocked metformin protective effects on H9C2 hypertrophy; b) metformin protects against hypoxia independently of Foxo1 pathway, therefore, strong hypertrophy of metformin-treated cells incubated in hypoxia is the result of Foxo1 knockdown, a potent hypertrophic stimulus. Consequently, further investigations are still required to clarify the mechanisms by which metformin exerts its cardioprotective effects.
Authors and Affiliations
N. V. Pasiechko, H. Ya. Loi, M. M. Korda, O. M. Oleshchuk
Keywords
Related Articles
- EP ID EP432728
- DOI 10.22141/2224-0721.14.7.2018.148779
- Views 52
- Downloads 0
The Menstrual Disorders in Women of Reproductive Age with Obesity
Introduction. In this article, the authors present the results of studies on reproductive health features in 25 women with obesity seeking medical help for infertility. Objective: to study the nature of menstrual disorde...
The Early Diagnosis of Hypothyroidism as a Factor in the Progression of Osteoarthritis and Comorbid Processes, the Features of Phytocorrection
Objective: to study the prevalence and forms of hypothyroidism in patients with osteoarthritis (OA) and to investigate the effect of phytomedication zobofit on the functional and morphological status of the thyroid gland...
The Use of Sugar Substitutes and Sweeteners in Diet Therapy of Diabetes and Obesity
The article provides a description of the main sugar substitutes and sweeteners that do not have negative impact on glycaemic parameters and can be used by patients with with diabetes mellitus and obesity without the fea...
Thyroid Disease in Women of Reproductive Age: Preconception Preparation and Management during Pregnancy
During pregnancy, the metabolism of iodine and thyroid hormone changes that is an important factor in the diagnosis and treatment of thyroid diseases in pregnant women and women who are planning to become pregnant. It is...
Cognitive Disorders in Young Patients with Diabetes Mellitus Type 1
The article presents the data on the assessment of cognitive function in young patients with diabetes type 1 and identification of possible risk factors. The presence of hypoglycemia, diabetic retinopathy has an impact o...